These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37563620)

  • 21. Tumor Cell-Derived IL1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer.
    Das S; Shapiro B; Vucic EA; Vogt S; Bar-Sagi D
    Cancer Res; 2020 Mar; 80(5):1088-1101. PubMed ID: 31915130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-1RA promotes oral squamous cell carcinoma malignancy through mitochondrial metabolism-mediated EGFR/JNK/SOX2 pathway.
    Yuan SF; Wang YM; Chan LP; Hung AC; Nguyen HDH; Chen YK; Hu SC; Lo S; Wang YY
    J Transl Med; 2023 Jul; 21(1):473. PubMed ID: 37461111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypomethylation of IL1RN and NFKB1 genes is linked to the dysbalance in IL1β/IL-1Ra axis in female patients with type 2 diabetes mellitus.
    Margaryan S; Kriegova E; Fillerova R; Smotkova Kraiczova V; Manukyan G
    PLoS One; 2020; 15(5):e0233737. PubMed ID: 32470060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-cell programming in pancreatic adenocarcinoma: a review.
    Seo YD; Pillarisetty VG
    Cancer Gene Ther; 2017 Mar; 24(3):106-113. PubMed ID: 27910859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic analysis of the interleukin-1 receptor antagonist and its homologue IL-1L1 in alopecia areata: strong severity association and possible gene interaction.
    Tazi-Ahnini R; Cox A; McDonagh AJ; Nicklin MJ; di Giovine FS; Timms JM; Messenger AG; Dimitropoulou P; Duff GW; Cork MJ
    Eur J Immunogenet; 2002 Feb; 29(1):25-30. PubMed ID: 11841485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. β Cell-Specific Deletion of the IL-1 Receptor Antagonist Impairs β Cell Proliferation and Insulin Secretion.
    Böni-Schnetzler M; Häuselmann SP; Dalmas E; Meier DT; Thienel C; Traub S; Schulze F; Steiger L; Dror E; Martin P; Herrera PL; Gabay C; Donath MY
    Cell Rep; 2018 Feb; 22(7):1774-1786. PubMed ID: 29444430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression of interleukine-1 receptor antagonist in rheumatoid arthritis: Association with IL1RN*2/2 genotype.
    Ramírez-Pérez S; De la Cruz-Mosso U; Hernández-Bello J; Martínez-Bonilla GE; Ramírez-Dueñas MG; Pereira-Suárez AL; Parra Rojas I; Martínez-López E; Macías-Barragán J; Muñoz-Valle JF
    Autoimmunity; 2017 Dec; 50(8):468-475. PubMed ID: 29226727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of interferon-gamma by tumor-sensitized T cells is essential for interleukin-12-induced complete tumor eradication.
    Lee NC; Tsung K; Norton JA
    Surgery; 2002 Aug; 132(2):365-8. PubMed ID: 12219036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipopolysaccharide of Aggregatibacter actinomycetemcomitans up-regulates inflammatory cytokines, prostaglandin E2 synthesis and osteoclast formation in interleukin-1 receptor antagonist-deficient mice.
    Mizutani H; Ishihara Y; Izawa A; Fujihara Y; Kobayashi S; Gotou H; Okabe E; Takeda H; Ozawa Y; Kamiya Y; Kamei H; Kikuchi T; Yamamoto G; Mitani A; Nishihara T; Noguchi T
    J Periodontal Res; 2013 Dec; 48(6):748-56. PubMed ID: 23586622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-1 Receptor Antagonist Has a Novel Function in the Regulation of Matrix Metalloproteinase-13 Expression.
    Goto H; Ishihara Y; Kikuchi T; Izawa A; Ozeki N; Okabe E; Kamiya Y; Ozawa Y; Mizutani H; Yamamoto G; Mogi M; Nakata K; Maeda H; Noguchi T; Mitani A
    PLoS One; 2015; 10(10):e0140942. PubMed ID: 26474296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-1 receptor antagonist mediates toll-like receptor 3-induced inhibition of trophoblast adhesion to endometrial cells in vitro.
    Montazeri M; Sanchez-Lopez JA; Caballero I; Maslehat Lay N; Elliott S; Fazeli A
    Hum Reprod; 2016 Sep; 31(9):2098-107. PubMed ID: 27412245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of interleukin-1 (alpha and beta), interleukin-2 secretion and surface expression of interleukin-2 receptor (IL-2R) by a novel cytokine interleukin-1 receptor antagonist (IL-1ra).
    Conti P; Panara MR; Porrini AM; Gambi D; Barbacane RC; Reale M; Bongrazio M; Dempsey RA
    Scand J Immunol; 1992 Jul; 36(1):27-33. PubMed ID: 1535451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.
    McIntyre KW; Stepan GJ; Kolinsky KD; Benjamin WR; Plocinski JM; Kaffka KL; Campen CA; Chizzonite RA; Kilian PL
    J Exp Med; 1991 Apr; 173(4):931-9. PubMed ID: 1826128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IFN-γ treatment protocol for MHC-I
    Stifter K; Krieger J; Ruths L; Gout J; Mulaw M; Lechel A; Kleger A; Seufferlein T; Wagner M; Schirmbeck R
    J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32868392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-operation of IL-1 and IL-2 on T-cell activation in mononuclear cell cultures.
    Verheyen J; Bonig H; Banning U; Shin DI; Mauz-Körholz C; Körholz D
    Immunol Invest; 2001 Nov; 30(4):289-302. PubMed ID: 11777281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD28-dependent differentiation into the effector/memory phenotype is essential for induction of arthritis in interleukin-1 receptor antagonist-deficient mice.
    Kotani M; Hirata K; Ogawa S; Habiro K; Ishida Y; Tanuma S; Horai R; Iwakura Y; Kishimoto H; Abe R
    Arthritis Rheum; 2006 Feb; 54(2):473-81. PubMed ID: 16453283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of Toll-Like Receptor 3 Induces Interleukin-1 Receptor Antagonist Expression by Activating the Interferon Regulatory Factor 3.
    Liu Y; Mo CF; Luo XY; Li H; Guo HJ; Sun H; Hu S; Li LM; Wang YT; Yang SX; Chang S; Zou Q
    J Innate Immun; 2020; 12(4):304-320. PubMed ID: 31865314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombin-PAR1 signaling in pancreatic cancer promotes an immunosuppressive microenvironment.
    Schweickert PG; Yang Y; White EE; Cresswell GM; Elzey BD; Ratliff TL; Arumugam P; Antoniak S; Mackman N; Flick MJ; Konieczny SF
    J Thromb Haemost; 2021 Jan; 19(1):161-172. PubMed ID: 33064371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of Interleukin 1 receptor antagonist in mesenchymal stem cell-based tissue repair and regeneration.
    Harrell CR; Markovic BS; Fellabaum C; Arsenijevic N; Djonov V; Volarevic V
    Biofactors; 2020 Mar; 46(2):263-275. PubMed ID: 31755595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.